Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Romana Ponziani

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Current Protein & Peptide Science|May 3, 2017
Sarcopenia in Patients with Advanced Liver DiseaseFrancesca Romana Ponziani, Antonio Gasbarrini
International Journal of Molecular Sciences|May 27, 2023
Editorial of Special Issues "Gut Microbiota-Host Interactions: From Symbiosis to Dysbiosis 2.0"Valentina Zuccaro, Francesca Romana Ponziani, Raffaele Bruno
Expert Review of Gastroenterology & Hepatology|December 5, 2015
Diagnosis and treatment of small intestinal bacterial overgrowthFrancesca Romana Ponziani, Viviana Gerardi, Antonio Gasbarrini
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Viral cirrhosis: an overview of haemostatic alterations and clinical consequencesFrancesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
International Journal of Environmental Research and Public Health|December 10, 2021
Intestinal Barrier in Human Health and DiseaseNatalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
Vaccines|April 27, 2024
Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut MicrobiotaCarlo Airola, Silvia Andaloro, Antonio Gasbarrini, et al.
Nutrients|June 10, 2023
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to CancerVittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 17, 2023
Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overviewRaffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinomaFrancesca Romana Ponziani, Alberto Nicoletti, Antonio Gasbarrini, et al.
Expert Review of Gastroenterology & Hepatology|June 14, 2015
Physiology and pathophysiology of liver lipid metabolismFrancesca Romana Ponziani, Silvia Pecere, Antonio Gasbarrini, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Current Protein & Peptide Science|May 3, 2017
Sarcopenia in Patients with Advanced Liver DiseaseFrancesca Romana Ponziani, Antonio Gasbarrini
International Journal of Molecular Sciences|May 27, 2023
Editorial of Special Issues "Gut Microbiota-Host Interactions: From Symbiosis to Dysbiosis 2.0"Valentina Zuccaro, Francesca Romana Ponziani, Raffaele Bruno
Expert Review of Gastroenterology & Hepatology|December 5, 2015
Diagnosis and treatment of small intestinal bacterial overgrowthFrancesca Romana Ponziani, Viviana Gerardi, Antonio Gasbarrini
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Viral cirrhosis: an overview of haemostatic alterations and clinical consequencesFrancesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
International Journal of Environmental Research and Public Health|December 10, 2021
Intestinal Barrier in Human Health and DiseaseNatalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
Vaccines|April 27, 2024
Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut MicrobiotaCarlo Airola, Silvia Andaloro, Antonio Gasbarrini, et al.
Nutrients|June 10, 2023
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to CancerVittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 17, 2023
Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overviewRaffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinomaFrancesca Romana Ponziani, Alberto Nicoletti, Antonio Gasbarrini, et al.
Expert Review of Gastroenterology & Hepatology|June 14, 2015
Physiology and pathophysiology of liver lipid metabolismFrancesca Romana Ponziani, Silvia Pecere, Antonio Gasbarrini, et al.
Pageof 17